ENCEPHALITIS

Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:  

  1. Bell JE, Arango JC, Robertson R, Brettle RP, Leen C, Simmonds P.  HIV and drug misuse in the Edinburgh cohort. J Acquir Immune Defic Syndr. 2002 Oct 1;31 Suppl 2:S35-42.

  2. Bosma GP, Middelkoop HA, Rood MJ, Bollen EL, Huizinga TW, van Buchem MA. Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2002 Oct;46(10):2665-72.

  3. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002 Nov;61(11):1013-21.

  4. Burudi EM, Marcondes MC, Watry DD, Zandonatti M, Taffe MA, Fox HS. Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. J Virol. 2002 Dec;76(23):12233-41.

  5. Gain P, Chiquet C, Thuret G, Drouet E, Antoine JC. Herpes simplex virus type 1 encephalitis associated with acute retinal necrosis syndrome in an immunocompetent patient. Acta Ophthalmol Scand. 2002 Oct;80(5):546-9.

  6. Hadden PW, Barry CJ. Images in clinical medicine. Herpetic encephalitis and acute retinal necrosis. N Engl J Med. 2002 Dec 12;347(24):1932.

  7. Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002 Oct;8(10):634-40.

  8. Horie T, Shen Y, Kajino K, Gaubin M, Bonomi G, Mani JC, Berezov A,Piatier-Tonneau D, Guardiola J, Hillard B, Rostami A, Greene M, Murali R.  Study of disabling T-cell activation and inhibiting T-cell-mediated immunopathology reveals a possible inverse agonist activity of CD4 peptidomimetics. Exp Mol Pathol. 2002 Oct;73(2):93-103.

  9. Lee KH, McKie VC, Sekul EA, Adams RJ, Nichols FT. Unusual encephalopathy after acute chest syndrome in sickle cell disease: acute necrotizing encephalitis. J Pediatr Hematol Oncol. 2002 Oct;24(7):585-8.

  10. Ljungman P. Beta-herpesvirus challenges in the transplant recipient. J Infect Dis. 2002 Oct 15;186 Suppl 1:S99-S109.

  11. Mantegazza R, Bernasconi P, Baggi F, Spreafico R, Ragona F, Antozzi C, Bernardi G, Granata T. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol. 2002 Oct;131(1-2):179-85.

  12. Martin K, Franco-Paredes C. Herpes encephalitis. Lancet. 2002 Oct 26;360(9342):1286.

Pathogenesis:

  1. Baum S. West Nile virus: time for prevention, not panic. As the virus spreads, the risk of severe illness remains low. Health News. 2002 Oct;8(10):3.

  2. Chase P. Ethical concerns with organ donation. S C Nurse. 2002 Oct-Dec;9(4):23.

  3. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res. 2002 Nov 1;70(3):462-73.

  4. Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002 Oct 15;186 Suppl 1:S91-8. Review.

  5. Rodriguez JJ, Parisien JP, Horvath CM.  Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol. 2002 Nov;76(22):11476-83.

Vaccines:

  1. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol  2002 Dec;76(23):12335-43

Therapy:

  1. Gupta SK; Verma VK; Parihar A. Herpes simplex encephalitis  JK Practitioner. 2002 Jan-Mar; 9(1): 53-4

  2. Quirk M. First treatment trial for West Nile infection begins. Lancet Infect Dis. 2002 Oct;2(10):589.

  3. Singh N; Syed Sadiq A; Singh V; Singh A Adaptogens anti stress agents a study focusing Indian plants. Antiseptic. 2002 Jun; 99(6): 198-201

 

Back